Advanced Search
Contact | Corporate | Help

Daily news email for May 25, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Zytoprotec Completes Phase I/II Trial of Novel Dialysate, Enters Into Negotiations with Global ...

ElexoPharm Receives 2.1 Million EUROSTARS Grant for Program Targeting Mitochondrial ...

Vetter Boosts Quality and Logistic Processes

Definiens Expands Functionality of Its Leading Solution for Quantitative Digital Pathology with ...

Antisense Pharma Internationalizes Management Board

 BioSpace
Japanese-American Men With Low Vitamin-D Diet Face Higher Stroke Risk, University of Hawaii Study

No New Neurons in the Human Olfactory Bulb, Karolinska Institute Study

Babies Zero in on "Just Right" to Learn, University of Rochester Study

Seaweed Chemical Could be Key to Beat Arthritis University of California, San Diego (UCSD) Study

Anti-Psychotic Drug Pushes Cancer Stem Cells Over the Edge, McMaster University Study

BioSpace - Breaking News
BG Medical Technologies Release: Raises the Bar for Again!

La Jolla Pharmaceutical Company Announces Results of Annual Stockholders Meeting

Biostem U.S. Corporation Announces $5,000,000 Financing Agreement Through Private Placement of Stock

Court Orders Dismissal of Cornerstone Therapeutics Inc. CUROSURF(R) Case

Immune Response BioPharma Terminates Blockbuster MS Drug NeuroVax Partnership Discussions With GlaxoSmithKline

Biotech News - Business Wire
MDxHealth : Assemblée Générale Ordinaire et Extraordinaire des actionnaires

MDxHealth: Annual and Extraordinary General Shareholders Meeting

Health Canada Authorizes New Aurora Plasma Collection System from Fenwal Inc.

Zurich Heart Center Presents Clinical Experience with eSVS® Mesh at International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

Groups Ask Senate to Reconsider NDAA Amendments Blocking Military Use of Alternative Energy

 Biotech News - PR Newswire
Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration

Marken Opens Branch Office In Seoul, South Korea

immatics Wins 2012 TiE50 Award

Peers Underscored As An Effective Counseling Tool

Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovana® Product
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
The June 2012 Issue of The Burrill Report

European Private Investment Fundraising Up 80 Percent

Military Veterans Support Alternative Fuels

Kythera Files to Go Public Under JOBS Act

International Doctors' Group Criticizes Gates Global Vaccines Plan

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Medtronic Resolute® Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes

AspenBio Appoints Diagnostics Industry Veteran Don Hurd as Senior Vice President and Chief Commercial Officer

New Clinical Procedures, Practices and Interventions to Be Demonstrated at National Healthcare Event

Texas Researchers Studying Breast Cancer Prevention, Minorities and More Effective Treatments with $8.4 Million in New Research Funding from Susan G. Komen for the Cure®

Tryton Announces Positive Clinical Data from More Than 900 Patients Treated with Its Bifurcation Stent System at EuroPCR 2012

 Clinical Trials - PR Newswire
PCA3 Test Featured at American Urological Association Meeting

UV-Blocking Contact Lenses May Have An Effect On Maintaining Eyes' Macular Pigment Density, Study Suggests

Allegheny General Hospital Hearing Specialists Introduce First-of-its-kind Therapy for Single-Sided Deafness and Conductive Hearing Loss

Uroplasty Announces Product Development and New Clinical Trial Initiatives

Les données de l'essai pivot de phase II du brentuximab vedotin (SGN-35) chez les patients souffrant de lymphome anaplasique à grandes cellules systémique en rechute ou réfractaire sont publiées dans le Journal d'oncologie clinique

 CNN Top Stories
Opinion: Get used to a life of layoffs

Space station catches 'a Dragon'

Passenger restrained on Miami flight

Rush hurricane preparations, Mexicans told

Finding a father's remains and a life
Contract Pharma
Onyx Scientific Appoints European BD Director

Takeda To Acquire Multilab

Clinilabs Opens New Phase I Unit

DSM Pharmaceutical Appoints President

Transgenomic Acquires Gene Logic Biorepository

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

 FDA News - Business Wire
Fera Pharmaceuticals Preparing Resupply of Methazolamide Tablets

FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine, Pfizer's Novel Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)

Taro Provides Results for Three Months Ended March 2012

BIO Lauds Senate Passage of User Fee Package

RetroSense Therapeutics Completes pre-IND Meeting for RST-001
FDA Press Releases
U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC

FDA-led research team discovers an autoimmune mechanism for serious drug-induced adverse reactions

FDA approves generic versions of blood thinner Plavix

FDA expands use for FilmArray Respiratory Panel

FDA issues alert on potential dangers of unproven treatment for multiple sclerosis

 FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

 FierceBiotech
UPDATED: Sangart stashes $50M funding for oxygenation drugs

GSK gambles on biotech partners after dubious M&A deal

Vertex finds key support for cystic fibrosis drug in Europe

Elan boss: Climate improved for Alzheimer's drugs

FDA panel mixed on Pfizer's rare disease drug
FierceBiotech IT
Broken link found in electronic clinical trial startups

Pfizer brings Lipitor brand to mobile app stores

Relay launches 'Bloomberg' for biopharma dealmakers

Memorial Day break; Twitter chat reminder

Ex-Apple CEO forecasts tech-driven change in medicine

 FierceBiotech Research
Scientists morph skin cells from heart failure patients into healthy cardiac tissue

New strategy reactivates genes to suppress cancer

Malaria's genetic secrets open door to new drug targets

2 proteins appear crucial for aggressive cancer metamorphosis

Celery extract shrinks difficult breast cancer tumor in mouse trials

 FiercePharma
EMA supports Pradaxa but seeks sharper warnings for bleeding

House could vote on FDA bill next week

E.U. panel recommends Inlyta for adults with kidney cancer

While we are off for holiday weekend, cargo thieves are not

FDA relies on health professionals, not recall, with Hospira overfills
FiercePharma Manufacturing
Recipharm snags $114 million loan, says it's shopping

UPDATED: Marshals descend on Crescendo Therapeutics

Recipharm snags $114 million loan, says its shopping

Heart attack test alert from Alere

FDA takes aim at Spanish drugmaker

 FierceVaccines
Flu shot cuts preterm births

Vitamin D boosts TB shot as cancer therapy

HIV vaccine carries its own adjuvant into clinical trials

Wishing you a happy HIV Vaccine Awareness Day

Vax-chemo combo offers some hope in pancreatic cancer

 Health News - BizJournals.com
Menendez, BIO call for new life sciences federal tax credits

Suffolk tapped to build Inova Fair Oaks medical office building

Glasses chain owned by Highmark to expand

A look at how much your doctor makes

Top of the List: Alabama's largest health & accident insurers
Health News - CNBC
HMO Stocks May Struggle Over Health Claim Costs

EU body wants new guidance on Boehringer clot drug

Europe clears Roche drug after contamination scare

U.S. panel split on Pfizer rare disease drug

Concord Medical: Focused On Growth Despite Share Slump

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Firefly Bags $500K from Massachusetts Life Science Center for miRNA Biomarker Platform

IMI Launches 223.7M Industry-Academia Program to Tackle Antibiotic Resistance

Nexavar Fails to Meet Primary Endpoint in Late-Stage NSCLC Study

France's Biotech Industry Faces Financing Challenge but Partnership Growth

Nexavar Fails to Meet Primary Endpoint in Phase III NSCLC Study
Marketwire - Pharma and Biotech
Study Validating miRview mets2 Published in The Oncologist

La Jolla Pharmaceutical Announces Results of Annual Stockholders Meeting

Daxor Corporation Announces Filing of Form N-Q for March 31, 2012 and Volumex Kit Sales for the First Quarter of 2012

Summit Corporation PLC : Summit Announces Initiation of Phase 1 Trial for the Treatment of Duchenne Muscular Dystrophy

MoneyTV with Donald Baillargeon, 5/25

 MassBio News
MassBio Applauds Senators Kerry & Brown for Work on Passage of User Fee Package

MassBio Honored with NORD's Power of Partnership Award

10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

 Medical Pharma - PR Newswire
SOCMA's Bulk Pharmaceuticals Task Force Hails Senate Passage of FDA User Fee Bill

Real Time Medical to Feature Diagnostic Imaging Software @ Innovation Showcase at e-Health 2012

Wound Care Publication to be Distributed Within USA Today Highlights Advancements In The Industry and Inspirational Survival Story From J.R. Martinez

StreamVenue Healthcare CEO Named People's Choice Winner

Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

 New York Times- Biotechnology
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research
New York Times- Pharmaceuticals
Senate Backs Bill to Speed Drugs and Avert Shortages

Senate Passes Bipartisan Bill on New Medicines

F.D.A. Panel Votes Against Expansion of Anticoagulant

Fake and Substandard Drugs Grow as Threat to Fight Malaria

Tailoring Treatments for Alcoholics

 OnBioVC
S.E.A. Medical Systems, Inc.: Series B $3M

Phosphate Therapeutics, Ltd.: Series A $13.8M

CrystalGenomics, Inc.: Series A $2.6M

Heat Biologics, Inc.: Series A $2.8M

CN Creative, Ltd: Series A $3.1M

 Outsourcing-Pharma
R&D and commercial work together to design trials, says DIA

Patheon launches CMC consultancy in face of restructuring plans

SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Pharmas must give patients voice says DIA Europe director
Pharma News - Business Wire
Research and Markets: Cough, Cold and Allergy (Hay Fever) Remedies in Japan

Quintiles Named Top Workplace in UK

BioScrip to Present at Jefferies 2012 Global Healthcare Conference

Pfizer's Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU

Samenvatting: Vertex krijgt Europese CHMP positief advies voor KALYDECO (ivacaftor)

 Pharma News - PharmiWeb
ICON Presents Successful Late Phase, Outcomes Research and Pricing Strategies at ISPOR 2012

BHI Raises Awareness of the Link Between Hearing Loss and Some Chronic Diseases During National Men's Health Week

Oncobiologics Fills Key Leadership Positions and Names Scientific Advisory Board

American Council of the Blind Applauds U.S. Senate for Including Accessible Prescription Drug Labeling Legislation in User Fee Authorization

ONYX STRENGTHENS COMMERCIAL TEAM

 Pharma News - PR Newswire
Watson to Present at the Jefferies 2012 Global Healthcare Conference

Depomed To Present At Jefferies 2012 Global Health Care Conference

Delcath Prices $20 Million Public Offering of Common Stock and Warrants

Takeda to Acquire Multilab, Enhancing its Business Infrastructure in Brazil

NORD Calls Senate Bill Most Important Since Orphan Drug Act
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

 PRWeb - Biotechnology
Telcare's Wireless-Enabled Blood Glucose Monitoring System Wins...

EquipNet to Auction Off Entire Contents of Closed Merck Facility

Containers First Indicates Shipping Containers Successful...

The ISHEID Meeting Makes a Donation of 2,500 Euros to The Berlin...

11 Scientists Funded to Move Arthritis Research Forward
PRWeb - Pharmaceuticals
REGISTRAT-MAPI Names Vice President, Clinical Operations EU

Franklin University Offers Enhanced Online Healthcare Information...

QHC Advisory Group, LLC, Adds Vice President, Business Development and...

Turmeric Found in Diabetes Support Supplements, a new product by...

Alcohol Rehab And Addiction Treatment Pioneer Dr. Mohammad Launches...

 Scientific American
How Can We Cope with the Dirty Water from Fracking

Just How Big Was the Biggest Earthquake

Dollars and Scents: The Chemistry of a Delicious Tomato

Why America's Love Affair with Cars Is No Accident

"Artificial Leaf" Hits Development Hurdle

 Sports - ESPN Basketball
Rider associate Baggett elevated to head coach

Texas-Arlington officially joining Sun Belt in '13

Rider promotes Baggett to head hoops coach

Binghamton goes with Dempsey to lead team

Binghamton turns to ex-Rider coach Dempsey
Sports News - ESPN
Vols dismiss tight end Clear 3 days after arrest

Source: Clemson, Swinney close to new deal

Sandusky-founded charity seeks OK to shutter

Clemson officials open to offers to leave ACC

WVU fans, friends pay tribute to late Stewart

 Xconomy Life Sciences
Xconomist of the Week: Evan Snyder'stem Cell Reality Check

Good for Some, Good for All

Nokia Joins X Prize in $2.25M Wireless Health 'sensing Challenge

SD Life Sciences Roundup: Takeda Consolidates, Startups Raise Cash

The 2012 New York ASCO Checklist

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012